Startup Name: Aesis Therapeutics
Stage: Pre seed
About: AESIS THERAPEUTICS is a Hispano-Italian dual spin-out Limited Company from the drug discovery small biotechs AROMICS and NAXOSPHARMA, with full operative access to research facilities, personnel, backgrounds, foregrounds and intellectual property from the parent Companies. The enterprise is legally incorporated in Jesi (AN, Italy), but agnostic as to the final geographical location. The Company is exclusively focused on developing therapeutics, taking validated compounds from Naxospharma and Aromics, initially through preclinical and early clinical development and then partner/license-out for late stage development and commercialization. The Management Team includes professionals with long experience in corporate R&D and know-how in project management, regulatory aspects and business operations within the oncology area. Some were deeply involved in the discovery and development of anticancer drugs which reached the global market (daunorubicin, doxorubicin, idarubicin, epirubicin, exemestane) or advanced clinical studies (minamestane, tallimustine, nemorubicin, sabarubicin). Highly passionate, knowledgeable and responsible people who know how to do the job because they have already done it, committed to de-risk third party investments.